Answers are grounded in this paper and cite their sources.
The Quick prothrombin time is sufficient for monitoring coumarin-type anticoagulants provided that satisfactory thromboplastin is used.
Since anticoagulants of the coumarin type have been reported to decrease at least four coagulation factors, there is doubt as to which test to use in the control of anticoagulant therapy. Early extensive experience showed the Quick prothrombin time alone to suffice for laboratory control of therapy with coumarin-type anticoagulants. Subsequent failures with this test are explained by the use of unsatisfactory thromboplastin.
No takes yet. Share an insight, caveat, or question.
Benson et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: